Common antidepressant may shield Parkinson's brains from toxic plaques
NCT ID NCT04497168
Summary
This study tested whether taking the antidepressant citalopram for over two years could slow the buildup of harmful brain plaques linked to thinking problems in Parkinson's disease. Researchers compared citalopram to a placebo pill in 58 older Parkinson's patients without depression. They used brain scans and thinking tests to see if the medication could protect brain areas involved in visual-spatial skills.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.